产品标题 产品货号 产品规格 厂家
Neurofibromin 2 (merlin) (NF2), transcript variant 7 from ORIGENE TECHNOLOGIESLY405605100 ugORIGENE TECHNOLOGIES
Neurofibromin 2 (merlin) (NF2), transcript variant 8 from ORIGENE TECHNOLOGIESLY405607100 ugORIGENE TECHNOLOGIES
Neurofilament, heavy polypeptide (NEFH) from ORIGENE TECHNOLOGIESLY412101100 ugORIGENE TECHNOLOGIES
Neurofilament, light polypeptide (NEFL) from ORIGENE TECHNOLOGIESLY416829100 ugORIGENE TECHNOLOGIES
Neurofilament, medium polypeptide (NEFM), transcript variant 1 from ORIGENE TECHNOLOGIESLY417338100 ugORIGENE TECHNOLOGIES
Neurogenic differentiation 1 (NEUROD1) from ORIGENE TECHNOLOGIESLY400891100 ugORIGENE TECHNOLOGIES
Neurogenic differentiation 4 (NEUROD4) from ORIGENE TECHNOLOGIESLY412030100 ugORIGENE TECHNOLOGIES
Neurogenic differentiation 2 (NEUROD2) from ORIGENE TECHNOLOGIESLY416831100 ugORIGENE TECHNOLOGIES
Neurogenin 1 (NEUROG1) from ORIGENE TECHNOLOGIESLY401855100 ugORIGENE TECHNOLOGIES
Neurogenin 3 (NEUROG3) from ORIGENE TECHNOLOGIESLY402827100 ugORIGENE TECHNOLOGIES
Neurogenic differentiation 6 (NEUROD6) from ORIGENE TECHNOLOGIESLY411595100 ugORIGENE TECHNOLOGIES
Neurogenin 2 (NEUROG2) from ORIGENE TECHNOLOGIESLY411396100 ugORIGENE TECHNOLOGIES
NEUROG1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4070291 kitORIGENE TECHNOLOGIES
NEUROG3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4247671 kitORIGENE TECHNOLOGIES
Neurog1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5109211 kitORIGENE TECHNOLOGIES
NEUROG2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4078531 kitORIGENE TECHNOLOGIES
Neurog2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5109221 kitORIGENE TECHNOLOGIES
Neurog3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5109231 kitORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS7003945x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS7003955x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, metastatic from ORIGENE TECHNOLOGIESCS6169395x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS7054535x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS7054525x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS7097935x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS7097945x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS7147735x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS5184145x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS5313275x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, metastatic from ORIGENE TECHNOLOGIESCS5498655x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, mucinous from ORIGENE TECHNOLOGIESCS5181655x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, mucinous from ORIGENE TECHNOLOGIESCS7053855x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, mucinous from ORIGENE TECHNOLOGIESCS7053845x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS8028625x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS8056295x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS8071405x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS5024235x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS5192515x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS8076975x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS5082375x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS5258745x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS6099325x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS6152395x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS5493105x5umORIGENE TECHNOLOGIES
SETD2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN224760BN1 kitORIGENE TECHNOLOGIES
SETD2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN224760LP1 kitORIGENE TECHNOLOGIES
SETD2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN224760RB1 kitORIGENE TECHNOLOGIES
SETD9 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4062251 kitORIGENE TECHNOLOGIES
SETD5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4121801 kitORIGENE TECHNOLOGIES
SETD6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4136561 kitORIGENE TECHNOLOGIES
SETD3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4145661 kitORIGENE TECHNOLOGIES
 |< < 4069 4070 4071 4072 4073 4074 4075 4076 4077 > >| 第 4069/6274 页